Search - tctmd.com

Displaying 661 - 680 of 785

Sort: Relevancy | Date

News Daily News

‘We Have to Go to Them’: New Global Initiative for Treating Rheumatic Heart Disease

Michael O'Riordan

August 06, 2018

News Daily News

New Consensus Statement: NOAC and Clopidogrel for Most A-fib Patients Treated With PCI

Michael O'Riordan

July 31, 2018

News Daily News

High-Risk Medical Device Approval Process in Europe Inches Towards Transparency

Michael O'Riordan

July 20, 2018

News Daily News

Discharge Against Medical Advice After PCI Rare but Deadly

Michael O'Riordan

July 17, 2018

News Daily News

FDA Recalls Valsartan-Containing Drugs After Detection of Carcinogen

Michael O'Riordan

July 16, 2018

News Daily News

USPSTF: Insufficient Evidence to Support CAC Score, hsCRP, or ABI for Risk Assessment

Michael O'Riordan

July 12, 2018

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Michael O'Riordan

June 22, 2018

Gender-neutral criteria and better transparency around physician salaries are among proposals under consideration as a draft resolution moves ahead.

News Daily News

AMA Takes on Gender Inequity, Including the Wage Gap

Michael O'Riordan

June 15, 2018

News Daily News

Do Not Screen Asymptomatic Adults For CVD With ECGs, Says USPSTF

Michael O'Riordan

June 12, 2018

News Daily News

Liability Reform Changes How Docs Manage Suspected Coronary Artery Disease

Michael O'Riordan

June 07, 2018

News Daily News

Class I Recall for Medtronic’s HeartWare HVAD System

Michael O'Riordan

June 04, 2018

News Conference News EuroPCR 2018

‘Transient’ STEMI Patients Can Be Immediately Treated or Safely Deferred to Next Day

Michael O'Riordan

May 24, 2018

News Conference News EuroPCR 2018

Big Data, Big Questions: Physicians and Innovators Consider AI’s Role in Clinical Care

Michael O'Riordan

May 21, 2018

News Conference News EuroPCR 2018

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Shelley Wood

May 17, 2018

News Daily News

PREDICT-1° CVD Risk Calculator, Based on Present-Day Patients, Beats ACC/AHA ‘Pooled Cohort’ Equations

Michael O'Riordan

May 10, 2018

News Daily News

Implantable Cardiac Monitor for High-Risk ACS Patients Wins FDA Approval

Michael O'Riordan

May 08, 2018

News Daily News

Alirocumab Price Slashed in Deal With Express Scripts

Michael O'Riordan

May 03, 2018

News Daily News

FDA Advisory Panel Says Celecoxib Is as Safe for Heart as Ibuprofen and Naproxen

Michael O'Riordan

April 25, 2018

News Daily News

FDA Advisors Take Fresh Look at Celecoxib Safety as PRECISION Aspirin Analysis Unveiled

Michael O'Riordan

April 24, 2018

News Daily News

The Higher the LDL, the Bigger the Mortality Benefit of Intensive Therapy: Meta-analysis

Michael O'Riordan

April 20, 2018

Advertisement

‘We Have to Go to Them’: New Global Initiative for Treating Rheumatic Heart Disease

New Consensus Statement: NOAC and Clopidogrel for Most A-fib Patients Treated With PCI

High-Risk Medical Device Approval Process in Europe Inches Towards Transparency

Discharge Against Medical Advice After PCI Rare but Deadly

FDA Recalls Valsartan-Containing Drugs After Detection of Carcinogen

USPSTF: Insufficient Evidence to Support CAC Score, hsCRP, or ABI for Risk Assessment

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

AMA Takes on Gender Inequity, Including the Wage Gap

Do Not Screen Asymptomatic Adults For CVD With ECGs, Says USPSTF

Liability Reform Changes How Docs Manage Suspected Coronary Artery Disease

Class I Recall for Medtronic’s HeartWare HVAD System

‘Transient’ STEMI Patients Can Be Immediately Treated or Safely Deferred to Next Day

Big Data, Big Questions: Physicians and Innovators Consider AI’s Role in Clinical Care

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

PREDICT-1° CVD Risk Calculator, Based on Present-Day Patients, Beats ACC/AHA ‘Pooled Cohort’ Equations

Implantable Cardiac Monitor for High-Risk ACS Patients Wins FDA Approval

Alirocumab Price Slashed in Deal With Express Scripts

FDA Advisory Panel Says Celecoxib Is as Safe for Heart as Ibuprofen and Naproxen

FDA Advisors Take Fresh Look at Celecoxib Safety as PRECISION Aspirin Analysis Unveiled

The Higher the LDL, the Bigger the Mortality Benefit of Intensive Therapy: Meta-analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content